ARTICLE | Company News
Kyto Biopharma Inc. deal
December 3, 2007 8:00 AM UTC
Undisclosed companies will manufacture murine antibodies for Kyto. Kyto will use the antibodies to develop humanized MAbs targeting vitamin B12 receptor to treat cancer. Financial terms were not disc...